Skip to content

Clinical trials

Observational Cardiomyopathy, Dilated trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Observational Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20042
20053
20061
20075
20082
20092
20101
20112
20122
20137
20147
20152
20165
20173
20188
20199
20205
20215
20225
20235
20245
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status32
Completed27
Recruiting25
Active, not recruiting5
Not yet recruiting3
Terminated3
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London6
McGill University Health Centre/Research Institute of the McGill University Health Centre3
Assiut University2
Beijing Institute of Heart, Lung and Blood Vessel Diseases2
Chinese Academy of Medical Sciences, Fuwai Hospital2
French Cardiology Society2
Göteborg University2
Hospital General Universitario Gregorio Marañon2
Johns Hopkins University2
National Heart Centre Singapore2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated100
Cardiomyopathy, Hypertrophic32
Heart Failure28
Cardiomyopathies17
Arrhythmogenic Right Ventricular Dysplasia12
Cardiomyopathy, Restrictive12
Death, Sudden, Cardiac11
Myocarditis8
Cardiovascular Diseases7
Heart Diseases7

Trials

Showing 51 to 75 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.